SIRAKOSS Ltd
medical devices
About
SIRAKOSS provides bone grafting solutions to surgeons. Our products enable the delivery of reliable bone healing in all patients. Our first formulation, Osteo3, is a unique, proprietary nanosynthetic bone graft substitute composed of novel inorganic granules. It provides significantly better healing in challenging models, supporting its potential for reliably achieving rapid patient recovery. SIRAKOSS has a unique focus on developing strong clinical data in support of product efficacy.
Technologies
Outlook
NetSuite
Microsoft Office 365
SharpSpring
Google Analytics
Mobile Friendly
Linkedin Marketing Solutions
Bootstrap Framework
Google Tag Manager
Cision
Keywords
bone graft substitutes
orthopedics
trauma
spine
medical devices
hospital & health care
Company Information
-
Employees 3
-
Founded 2010
-
Total Funding $4800000
Location
Aberdeen, Scotland, United Kingdom, AB25 2ZD